Expression of the active notch1 decreases MTC tumor growth in vivo

Journal of Surgical Research

Volumn 171, Issue 1, 2011, Pages 23-27

  Jaskula Sztul, Renata ^a   Pisarnturakit, Pongthep ^a   Landowski, Michael ^a   Chen, Herbert ^a   Kunnimalaiyaan, Muthusamy ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

achaete scute complex like 1; chromogranin A; medullary thyroid cancer (MTC); Notch1 pathway; tumor suppressor; xenograft model

Indexed keywords

CHROMOGRANIN A; DOXYCYCLINE; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR MASH1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS POTENTIAL; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYROID MEDULLARY CARCINOMA; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ACHAETE-SCUTE COMPLEX GENOME REGION; ANIMALS; ANTI-BACTERIAL AGENTS; CARCINOMA, MEDULLARY; CARCINOMA, NEUROENDOCRINE; CHROMOGRANIN A; DOXYCYCLINE; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 80052738552     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.03.035     Document Type: Article

References (26)

1. H. Chen, J.R. Roberts, and D.W. Ball Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection Ann Surg 227 1998 887
2. H. Chen, R. Udelsman, and M.A. Zeiger Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors Oncol Reports 4 1997 775
3. R.S. Sippel, J.E. Carpenter, and M. Kunnimalaiyaan The role of human achaete-scute homolog-1 in medullary thyroid cancer cells Surgery 134 2003 866
4. R.S. Sippel, M. Kunnimalaiyaan, and H. Chen Current management of medullary thyroid cancer Oncologist 13 2008 539
5. M. Kunnimalaiyaan, A.M. Vaccaro, and M.A. Ndiaye Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells J Biol Chem 281 2006 39819
6. M. Kunnimalaiyaan, and H. Chen Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors Oncologist 12 2007 535
7. H. Chen, A. Thiagalingam, and H. Chopra Conservation of the Drosophila lateral inhibition pathway in human lung cancer: A hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression Proc Natl Acad Sci USA 94 1997 5355
8. J.L. de la Pompa, A. Wakeham, and K.M. Correia Conservation of the Notch signalling pathway in mammalian neurogenesis Development 124 1997 1139
9. M. Ishibashi, S.L. Ang, and K. Shiota Targeted disruption of mammalian hairy and enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects Genes Dev 9 1995 3136
10. M. Kunnimalaiyaan, S. Yan, and F. Wong Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells Surgery 138 2005 1137
11. H. Soderholm, E. Ortoft, and I. Johansson Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells Biochem Biophys Res Commun 256 1999 557
12. A. Vaccaro, H. Chen, and M. Kunnimalaiyaan In vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer Anticancer Drugs 17 2006 849
13. M. Borges, R.I. Linnoila, and H.J. van de Velde An achaete-scute homologue essential for neuroendocrine differentiation in the lung Nature 386 1997 852
14. S. Massironi, D. Conte, and V. Sciola Plasma chromogranin a response to octreotide test: Prognostic value for clinical outcome in endocrine digestive tumors Am J Gastroenterol 105 2010 2072
15. M. Peracchi, C. Gebbia, and G. Basilisco Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids Eur J Endocrinol 152 2005 443
16. M. Gossen, S. Freundlieb, and G. Bender Transcriptional activation by tetracyclines in mammalian cells Science 268 1995 1766
17. Q. ZhuGe, M. Zhong, and W. Zheng Notch-1 signaling is activated in brain arteriovenous malformations in humans Brain 132 2009 3231
18. A.J. Mouland, S. Bevan, and J.H. White Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression J Biol Chem 269 1994 6918
19. V. Sriuranpong, M.W. Borges, and C.L. Strock Notch signaling induces rapid degradation of achaete-scute homolog 1 Mol Cell Biol 22 2002 3129
20. D.Y. Greenblatt, M. Cayo, and L. Ning Suberoyl bis-hydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells J Gastrointest Surg 11 2007 1515
21. D.Y. Greenblatt, A.M. Vaccaro, and R. Jaskula-Sztul Valproic acid activates Notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells Oncologist 12 2007 942
22. D.Y. Greenblatt, M.A. Cayo, and J.T. Adler Valproic acid activates notch1 signaling and induces apoptosis in medullary thyroid cancer cells Ann Surg 247 2008 1036
23. L. Ning, D.Y. Greenblatt, and M. Kunnimalaiyaan Suberoyl bis-hydroxamic acid activates notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells Oncologist 13 2008 98
24. L. Ning, R. Jaskula-Sztul, and M. Kunnimalaiyaan Suberoyl bis-hydroxamic acid activates Notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma Ann Surg Oncol 15 2008 2600
25. S.N. Pinchot, R. Jaskula-Sztul, and L. Ning Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method Cancer 117 2010 1386
26. M. Truong, M.R. Cook, and S.N. Pinchot Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer Ann Surg Oncol 2010